a Skeletal Biology Laboratory, School of Biological and Population Health Sciences, Oregon State University, Corvallis, Oregon 97331.
c Nuclear Science and Engineering, Oregon State University, Corvallis, Oregon 97331.
Radiat Res. 2019 May;191(5):413-427. doi: 10.1667/RR15164.1. Epub 2019 Mar 14.
Total-body irradiation (TBI) followed by transfer of bone marrow cells from donors is routinely performed in immunology research and can be used to manipulate differentiation and/or function of bone cells. However, exposure to high-dose radiation can result in irreversible osteopenia, and transfer of heterogeneous cell populations can complicate interpretation of results. The goal of this research was to establish an approach for reconstituting bone marrow using small numbers of purified donor-derived hematopoietic stem cells (HSCs) without negatively affecting bone metabolism. Gamma-irradiated (9 Gy) WBB6F1 mice were engrafted with bone marrow cells (5 × 10 cells) or purified HSCs (3,000 cells) obtained from GFP transgenic mice. analysis and differentiation assays performed two months later established that both methods were effective in reconstituting the hematopoietic compartment with donor-derived cells. We confirmed these findings by engrafting C57Bl/6 (B6) mice with bone marrow cells or purified HSCs from CD45.1 B6 congenic mice. We next performed adoptive transfer of purified HSCs (750 cells) into WBB6F1 and radiosensitive Kit mice and evaluated the skeleton two months later. Minimal differences were observed between controls and WBB6F1-engrafted mice that received fractionated doses of 2 × 5 Gy. Kit mice lost weight and became osteopenic after 2 × 5 Gy irradiations but these abnormalities were negligible after 5 Gy irradiation. Importantly, adoptive transfer of wild-type cells into Kit mice restored normal Kit expression in bone marrow. Together, these findings provide strong evidence for efficient engraftment with purified HSCs after lethal TBI with minimal collateral damage to bone. This approach will be useful for investigating mechanisms by which hematopoietic lineage cells regulate bone metabolism.
全身照射(TBI)后接受供者的骨髓细胞移植在免疫学研究中常规进行,可用于操纵骨细胞的分化和/或功能。然而,暴露于高剂量辐射会导致不可逆转的骨质疏松症,并且异质细胞群体的转移会使结果的解释复杂化。本研究的目的是建立一种方法,使用少量纯化的供体来源造血干细胞(HSCs)重建骨髓,而不会对骨代谢产生负面影响。用γ射线(9 Gy)照射 WBB6F1 小鼠,然后移植来自 GFP 转基因小鼠的骨髓细胞(5×10 个细胞)或纯化的 HSCs(3000 个细胞)。两个月后进行的分析和分化测定表明,这两种方法都能有效地用供体来源的细胞重建造血区室。我们通过将 C57Bl/6(B6)小鼠与来自 CD45.1 B6 同基因小鼠的骨髓细胞或纯化的 HSCs 进行移植,证实了这些发现。接下来,我们将纯化的 HSCs(750 个细胞)进行过继转移到 WBB6F1 和辐射敏感的 Kit 小鼠中,并在两个月后评估骨骼。在接受 2×5 Gy 分次剂量的 WBB6F1 移植小鼠和对照组之间观察到最小的差异。接受 2×5 Gy 照射的 Kit 小鼠体重减轻并出现骨质疏松症,但在接受 5 Gy 照射后这些异常现象可以忽略不计。重要的是,将野生型细胞过继转移到 Kit 小鼠中可恢复骨髓中 Kit 的正常表达。总之,这些发现为在致命性 TBI 后用纯化的 HSCs 进行高效移植提供了有力证据,对骨骼的附带损伤最小。这种方法将有助于研究造血谱系细胞调节骨代谢的机制。